The recent arrival of the 40mg Tirzepatide dose represents a seemingly significant advancement in the approach of type 2 diabetes . This therapy builds upon the prior success of lower dosages , showing impressive results in lowering blood glycemic control and promoting weight loss . Experts are exploring its full impact on cardiovascular health and